News for Biostage, Inc. (BSTG)

With U.S. stock futures trading higher this morning on Friday, some of the stocks that may grab investor focus today are as follows: Kadant Inc. (NYSE: KAI) announced plans to acquire Key Knife, Inc. for approximately $156 million in cash. Kadant shares fell 0.4% to close at $284.23 on Thursday.

/PRNewswire/ -- Purcell & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of...

/PRNewswire/ -- Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the "Company"), a clinical-stage biotechnology company developing the technology to regenerate...

HOLLISTON, Mass., May 31, 2023 (GLOBE NEWSWIRE) -- Biostage, Inc. (OTCQB: BSTG) (“Biostage” or the “Company”), a clinical-stage biotechnology company...

HOLLISTON, Mass., April 10, 2023 (GLOBE NEWSWIRE) -- Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the "Company"), a cell-therapy biotechnology company...

HOLLISTON, Mass., April 06, 2023 (GLOBE NEWSWIRE) -- Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the "Company"), a cell-therapy biotechnology company...

Biostage Announces Chairman and CEO Transition

/PRNewswire/ -- Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the "Company"), a clinical-stage biotechnology company developing regenerative-medicine treatments...

Regenerative medicine developer Biostage (BSTG) has scrapped plans for an uplisting and accompanying public offering. Read more here.